Advance Dravyaguna -The Materia Medica
Book Specification
Item Code: | NAQ539 |
Author: | Dr. Chandni Gupta |
Publisher: | Chaukhambha Prakashan |
Language: | English |
Edition: | 2018 |
ISBN: | 9789386735645 |
Pages: | 184 |
Cover: | PAPERBACK |
Other Details | 8.00 X 5.00 inch |
Weight | 200 gm |
Book Description
It gives me immense pleasure to write a foreword to the "Advanced Dravyaguna " authorized by Dr. Chadani Gupta . The Book is facilitating various modes of learning practices in Dravyaguna by considering attention to Dravyaguna and Ayurveda in current scenario. The book aptly presents a modern, luced and concise account of advancement in the field Dravyaguna is a branch Shastra. Most of the topic is explained in the form of tables , flow charts and diagrams to give clarity to the subject. Aushadha (a dravya) is one of the three pillar of all the eight branches of Ayurveda. Dravyaguna is a branch which explains the properties and safe usage of treasure of dravya especially of plant origin. But in present scenario many advanced topic such as Nutraceuticals, consmeceuticals , pharmacovigilance, pharmacogenomics, animal experiments etc. are incorporated in the field of Dravyaguna to make it more exientific and advanced . So this book is very helpful for all U.G. ,P.G. and Phd students and for teachers also as it gives concise and to the point explanation of a topic . The author need to be congratulated for her pioneering venture and it is hoped that many more books in this area will be brought in function.
1 | Importance of Namagyana of dravya | 1-4 |
2 | Anuktadravyas | 4-5 |
3 | Methods of standardisation and quality control | 6-11 |
4 | Pharmacognostical study of different parts of the plant | 11-15 |
5 | Knowledge of tissue culture techniques | 16-19 |
6 | Knowledge of genetically modified plants | 20-21 |
7 | Cultivation of medicinalplants | 21-27 |
8 | Knowledge of biodiversity | 28-30 |
9 | Endangered species | 30 |
10 | Knowledge of TKDL | 31-32 |
11 | Drugs and Cosmetic Act | 33-34 |
12 | Drugs and Magic remedies act (objectionable advertisements act 1954, rules 1955) | 35-36 |
13 | Intellectual property right | 36-43 |
14 | Regulations pertaining to import and export of Ayurvedic drugs | 43-47 |
15 | Basic concepts of pharmacology | 48-55 |
16 | Basic knowledge on experimental pharmacology | 55-57 |
16.1 | Analgesics | 57-59 |
16.2 | Antipyretics | 59-60 |
16.3 | Anti-inflammatory | 60-62 |
16.4 | Anti-diabetic | 62 |
16.5 | Anti-hypertensive | 63-64 |
16.6 | Anti-ulcer | 65 |
16.7 | Cardioprotective | 65-66 |
16.8 | Hepatoprotective | 66-67 |
16.9 | Diuretic | 67-68 |
16.10 | CNS activity | 68-70 |
16.11 | Anti-microbial | 70-71 |
17 | Knowledge of pharmacovigilance | 71-76 |
18 | Adverse drug reactions | 77-83 |
19 | Clinical pharmacology | 83-87 |
20 | Clinical drug research as per GCP guidelines | 88-92 |
21 | Pharmacogenomics | 92-97 |
22 | General awareness ofAharyogi (Neutraceuticals) | 97-104 |
23 | Soundaryaprasadana (cosmoceuticals) | 104-107 |
24 | Food additives | 107-109 |
25 | Excipients | 109-111 |
26 | Plant extracts | 111-114 |
27 | Food colours | 114-116 |
28 | Flavouring agents | 117-118 |
29 | Preservatives | 118-119 |
30 | API (Ayurvedic Pharmacopoeia of India) | 120-123 |
31 | BHP (british herbal pharmacopoeia 1996) | 123-124 |
32 | Reverse pharmacology' | 125-128 |
33 | Toxicological evaluation ofAyurvedic drugs | 129-133 |
34 | Evaluation of organized and unorganized drugs | 133-136 |
35 | Adulteration of herbal drugs | 137-142 |
36 | Deterioration of herbal drugs | 142-153 |
37 | Pharmacognosy | 154-163 |
38 | Probability of adverse drug interaction of few herbs with Anaesthetic drugs | 164-170 |
39 | Pharmacoepidemiology | 171-176 |
Bibliography | 177 |
**Contents and Sample Pages**